Lucide Ledger

A filing-first public record from Lucide House.

Issue 000 | U.S. Pilot | US

KTTA

Pasithea Therapeutics Corp.

Passing Verified 10-Q | 2026-05-15 Filing currency: USD
Open Filing Back to Register
Margin of Safety 73.2%

GNNI internal calculation. Market context inputs are retained internally and are not displayed.

Current Assets
52,731,456USD
Total Liabilities
1,542,451USD
NCAV
51,189,005USD
Cash
50,400,377USD
NCAV per share
2.05USD/share
Evidence
5 annual | 18 quarterly

Business Profile

Checklist-driven facts extracted from filing text. Missing fields stay visible.

Business profile not generated.

Run python -m application.cli.business_profile run --market US --one KTTA, then regenerate the site.

Known Unknowns

Only 18 quarterly periods available from Data Vault for this company.

Medium | Share Count

Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2025-12-31
10-K
USD
2024-12-31
10-K
USD
2023-12-31
10-K
USD
2022-12-31
10-K
USD
2021-12-31
10-K
USD
Revenue n/a n/a n/a 486,559 15,062
Operating Income -20,857,295 -14,249,962 -15,979,361 -14,816,321 -4,507,413
Net Income -20,427,683 -13,904,584 -15,961,658 -13,936,452 -2,173,521
Cash From Operations -15,211,490 -13,923,438 -12,814,133 -14,561,921 -3,174,058
Capex n/a n/a -34,301 -374,889 -21,503
Free Cash Flow n/a n/a -12,848,434 -14,936,810 -3,195,561
Cash And Equivalents 55,158,939 6,922,729 16,331,052 33,146,895 52,966,706
Accounts Receivable n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a
Total Current Assets 56,459,084 7,368,315 16,692,154 34,076,693 53,300,457
Total Assets 60,240,070 16,064,719 26,116,858 45,180,089 53,320,581
Total Current Liabilities 4,973,961 1,119,871 2,634,040 1,877,634 447,280
Total Liabilities 5,020,832 1,282,043 2,718,406 2,681,841 1,900,080
Shareholders Equity 55,219,238 14,782,676 23,398,452 42,498,248 51,420,501
Shares Outstanding 23,091,062 1,394,263 1,041,582 26,043,406 23,008,371
Shares Outstanding Diluted n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 7,031,050 1,096,082 1,226,600 25,251,756 10,404,668
Weighted Avg Shares Basic 7,031,050 1,096,082 1,226,600 25,251,756 10,404,668
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Only 18 quarterly periods available from Data Vault for this company.

Metric
2026-03-31
10-Q
USD
2025-12-31
10-K
USD
2025-09-30
10-Q
USD
2025-06-30
10-Q
USD
2025-03-31
10-Q
USD
2024-12-31
10-K
USD
2024-09-30
10-Q
USD
2024-06-30
10-Q
USD
2024-03-31
10-Q
USD
2023-12-31
10-K
USD
2023-09-30
10-Q
USD
2023-06-30
10-Q
USD
2023-03-31
10-Q
USD
2022-12-31
10-K
USD
2022-09-30
10-Q
USD
2022-06-30
10-Q
USD
2022-03-31
10-Q
USD
2021-09-30
10-Q
USD
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 240,712 218,608 13,581 13,658 n/a
Operating Income -4,876,644 -10,256,162 -3,110,055 -3,810,899 -3,680,179 -3,259,550 -3,004,604 -3,945,034 -4,040,774 -5,148,782 -3,789,326 -3,828,701 -3,212,552 -5,080,877 -4,250,813 -3,080,094 -2,404,537 n/a
Net Income -2,869,482 -10,110,868 -3,037,420 -3,716,157 -3,563,238 -3,177,661 -2,999,834 -3,866,249 -3,860,840 -5,048,159 -3,612,590 -3,763,230 -3,537,679 -5,117,688 -4,586,130 -2,658,394 -1,574,240 n/a
Cash From Operations -4,787,220 -5,396,822 -2,890,025 -3,868,886 -3,055,757 -2,443,036 -3,120,451 -4,038,866 -4,321,085 -3,294,344 -3,237,845 -3,079,666 -3,202,278 -4,418,691 -5,238,722 -2,377,030 -2,527,478 n/a
Capex n/a n/a n/a n/a n/a n/a n/a n/a n/a 36 22,659 -3,108 -53,888 -25,265 -197,447 -38,310 -113,867 n/a
Free Cash Flow n/a n/a n/a n/a n/a n/a n/a n/a n/a -3,294,308 -3,215,186 -3,082,774 -3,256,166 -4,443,956 -5,436,169 -2,415,340 -2,641,345 n/a
Cash And Equivalents 50,400,377 55,158,939 4,122,953 7,217,052 5,341,278 6,922,729 9,361,169 7,967,569 12,009,347 16,331,052 19,584,690 26,647,633 29,914,063 33,146,895 42,398,233 47,940,075 50,321,206 20,565,319
Total Current Assets 52,731,456 56,459,084 5,529,226 8,636,599 6,124,940 7,368,315 9,778,772 8,642,465 13,192,898 16,692,154 20,771,268 28,036,901 31,113,317 34,076,693 44,469,392 48,614,283 50,949,946 21,033,846
Total Liabilities 1,542,451 5,020,832 1,423,982 1,830,697 1,680,199 1,282,043 823,975 1,488,124 2,524,630 2,718,406 2,283,805 2,559,197 2,909,790 2,681,841 2,819,488 1,554,160 1,101,187 4,567,296
Shares Outstanding 24,939,948 23,091,062 7,443,577 7,443,577 2,705,263 1,394,263 1,044,914 1,044,081 1,043,248 1,041,582 20,836,623 26,143,407 26,126,740 26,043,406 26,548,688 26,698,688 23,008,371 13,208,371
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 24,337,812 7,031,050 7,443,577 5,641,251 2,211,207 1,096,082 1,044,144 1,043,312 1,042,479 1,226,600 25,784,010 26,128,022 26,073,036 25,251,756 26,548,688 23,444,135 23,008,371 8,956,197
Weighted Avg Shares Basic 24,337,812 7,031,050 7,443,577 5,641,251 2,211,207 1,096,082 1,044,144 1,043,312 1,042,479 1,226,600 25,784,010 26,128,022 26,073,036 25,251,756 26,548,688 23,444,135 23,008,371 8,956,197
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets 52,731,456USD us-gaap:AssetsCurrent 2026-03-31 1.00 sec/companyfacts/cik=0001841330/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001841330\companyfacts.json
Total Liabilities 1,542,451USD us-gaap:Liabilities 2026-03-31 1.00 sec/companyfacts/cik=0001841330/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001841330\companyfacts.json
Cash 50,400,377USD us-gaap:CashAndCashEquivalentsAtCarryingValue 2026-03-31 1.00 sec/companyfacts/cik=0001841330/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001841330\companyfacts.json
Shares Outstanding 24,939,948 us-gaap:CommonStockSharesOutstanding 2026-03-31 1.00 sec/companyfacts/cik=0001841330/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001841330\companyfacts.json
NCAV 51,189,005USD derived 2026-03-31 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share 2.05USD derived 2026-03-31 n/a company-evidence-v1 | NCAV / shares_outstanding
Margin of Safety 73.2% derived 2026-03-31 n/a gnni_publication_pack | internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source
Data Vault
Data Vault Root
D:\Projects\The Data Vault
CIK
0001841330
Company ID
n/a
Selected Annual Source
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001841330\companyfacts.json
Selected Quarterly Source
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001841330\companyfacts.json
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
15
Imported At
2026-07-04T23:04:33+00:00
Rendered At
2026-07-05T09:06:29+00:00

Run Audit

Mary Run
1ec055d81d1a42a39490a83bb9e1f22f
Mary As Of
2026-07-03
Accession
0001213900-26-057837
CIK
0001841330
Mary Filing Date
2026-05-15
Filing Currency
USD
Internal Discount
73.2%
Source State
Verified
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-05-15; mary_accession=0001213900-26-057837; mary_cik=0001841330; gnni_supporting_filing_date=2026-05-15; internal_discount=0.732033; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Archive